Junyu Long

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Inner Mongolia University of Science and Technology, Inner Mongolia Medical College Hospital, Inner Mongolia Medical University · ORCID：0000-0001-5745-7165

发表论文 139 篇 · 总被引 3924 次 · h-index 35

代表论文

• Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma (2024 · BMC Medicine · 被引 46)
• Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer (2024 · Biomarker Research · 被引 37)
• Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study (2023 · Cancer Immunology Immunotherapy · 被引 34)
• Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments (2024 · Molecular Cancer · 被引 24)
• Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study (2024 · International Journal of Surgery · 被引 21)
• Burden of type 2 diabetes mellitus and risk factor attribution among older adults: A global, regional, and national analysis from 1990 to 2021, with projections up to 2040 (2025 · Diabetes Obesity and Metabolism · 被引 16)